Skip to main content
Signal8
Jaumot Frank E profile photo

Frank E. Jaumot

CIK: 0001303609

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nutex Health Inc. logo
NUTX

Nutex Health Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Nutex Health Inc. logo
    NUTX

    Nutex Health Inc.

    Jul 31, 2026
    Exercise(M)
    Direct
    603 shares-
  • Nutex Health Inc. logo
    NUTX

    Nutex Health Inc.

    Apr 23, 2026
    Award(A)

    Restricted Stock Units (RSUs)

    Direct
    823 shares-
  • Nutex Health Inc. logo
    NUTX

    Nutex Health Inc.

    Mar 20, 2026
    Purchase(P)
    Direct
    150 shares at avg. $93.56$14K
  • Nutex Health, Inc. logo
    NUTX

    Nutex Health, Inc.

    Jul 14, 2025
    Award(A)

    Restricted Stock Units (RSUs)

    Direct
    603 shares-

1-4 of 4

About Jaumot Frank E

Jaumot Frank E (SEC CIK 0001303609) files insider reports with the SEC as Director of Nutex Health Inc. (NUTX).

Signal8 holds 5 ownership filings by Jaumot Frank E (1 Form 3, 4 Form 4), filed between Aug 4, 2025 and Aug 3, 2026. Those filings report 4 transactions, from Jul 14, 2025 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jaumot Frank E's filings is in HOUSTON, TX.

Recent filings by Jaumot Frank E

  • Jul 31, 2026: Option exercise of NUTX shares (Form 4, code M).
  • Apr 23, 2026: Grant or award of NUTX derivative securities (Form 4, code A).
  • Mar 20, 2026: Open-market purchase of NUTX shares (Form 4, code P).
  • Jul 14, 2025: Grant or award of NUTX derivative securities (Form 4, code A).

Other insiders filing for Nutex Health Inc. (NUTX)

How to read Form 4 transaction codes